Evidence map›Paper›PMID 32616678›Full record

SynthesisGut and liver2021

Efficacy and Safety of Peroral Endoscopic Myotomy in Achalasia Patients with Failed Previous Intervention: A Systematic Review and Meta-Analysis.

Shali Tan, Chunyu Zhong, Yutang Ren, Xujuan Luo, Jin Xu, Xiangsheng Fu, Yan Peng, Xiaowei Tang

Open access · diamondAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Gut and liver, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Saudi Gastroenterology Association (SGA) clinical care pathway and standards of care for peroral endoscopic myotomy (POEM) in achalasia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  3. The per-oral endoscopic myotomy (POEM) era in Saudi Arabia: Bridging tertiary-center experience with clinical care pathways.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Surgical Options for End-Stage Achalasia.Current gastroenterology reports · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shali TanDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0002-8314-9868
Chunyu ZhongDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0002-6934-3795
Yutang RenDepartment of Gastroenterology, Beijing Tsinghua Changgung Hospital, Tsinghua University School of Clinical Medicine, Beijing, China.ORCID 0000-0002-8972-5846
Xujuan LuoDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0002-3651-8691
Jin XuDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0001-7005-5865
Xiangsheng FuDepartment of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.ORCID 0000-0001-8889-3314
Yan PengDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0002-4007-0850
Xiaowei TangDepartment of Gastroenterology, Affiliated Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0001-9947-0720
Affiliated Hospital of Southwest Medical University · CNBeijing Tsinghua Chang Gung Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroral endoscopic myotomy (POEM) has emerged as a rescue treatment for recurrent or persistent achalasia after failed initial management. Therefore, we aimed to investigate the efficacy and safety of POEM in achalasia patients with failed previous intervention. We searched the MEDLINE, Embase, Cochrane, and PubMed databases using the queries "achalasia," "peroral endoscopic myotomy," and related terms in March 2019. Data on technical and clinical success, adverse events, Eckardt score and lower esophageal sphincter (LES) pressure were collected. The pooled event rates, mean differences (MDs) and risk ratios (RR) were calculated. A total of 15 studies with 2,276 achalasia patients were included. Overall, the pooled technical success, clinical success and adverse events rate of rescue POEM were 98.0% (95% confidence interval [CI], 96.6% to 98.8%), 90.8% (95% CI, 88.8% to 92.4%) and 10.3% (95% CI, 6.6% to 15.8%), respectively. Seven studies compared the clinical outcomes of POEM between previous failed treatment and the treatment na&#239;ve patients. The RR for technical success, clinical success, and adverse events were 1.00 (95% CI, 0.98 to 1.01), 0.98 (95% CI, 0.92 to 1.04), and 1.17 (95% CI, 0.78 to 1.76), respectively. Overall, there was significant reduction in the pre- and post-Eckardt score (MD, 5.77; p<0.001) and LES pressure (MD, 18.3 mm Hg; p<0.001) for achalasia patients with failed previous intervention after POEM. POEM appears to be a safe, effective and feasible treatment for individuals who have undergone previous failed intervention. It has similar outcomes in previously treated and treatment-na&#239;ve achalasia patients.

Indexed as

Esophageal AchalasiaMyotomyNatural Orifice Endoscopic SurgeryEsophageal Sphincter, LowerEsophagoscopyHumansTreatment OutcomeEsophageal achalasiaMeta-analysisPyloromyotomySafetyTreatment failure

Identifiers

PMID32616678
PMCPMC7960968
OpenAlexW3040637574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.